Golden Rock Global Plc Overview
Golden Rock Global plc is a Jersey-incorporated, London Main Market-listed cash shell formed in 2016 as a fintech-focused special purpose acquisition company. It has no revenue, no employees and no operating assets; its sole economic purpose is to complete a reverse takeover that converts the listed shell into an operating company. Over ten years it has signed heads of terms on three occasions — with Bolt Global (blockchain media/DeFi, 2021–2023), 2Mee (influencer messaging technology, 2023–2024) and SSS Matrix Corp. (2026, since rebranded StarEdge Digital Infrastructure) — the first two of which collapsed. The company's investment case therefore rests entirely on whether its current RTO with StarEdge, a datacenter-focused hardware, energy-efficiency and quantum-security business, completes on acceptable terms. Following a 2025 recapitalisation via convertible loan notes and warrants, the shell held £0.73 million of cash at 30 June 2026, but carries very significant dilution overhang, a qualified audit opinion and documented governance lapses.
Company's own description
In its FY2025 Directors' Report (RNS 14 May 2026), the company describes its principal activity as seeking and completing a reverse takeover in the financial or other technologies sectors. The notes to the same accounts describe the principal activity as seeking acquisition opportunities focused on the financial and technology sector. The company's IPO announcement (31 October 2016) framed it as a SPAC formed to undertake one or more acquisitions of a target company or business in the fintech sector. The H1 2026 interim statements describe the single operating segment as "investing activity".
Independent characterisation
Golden Rock Global is best characterised as a listed corporate vehicle (a "clean shell") whose only asset of strategic value is its Main Market listing. Its business model is not to generate revenue but to:
-
Maintain the listing and regulatory compliance at minimum cost (audit, registrar, legal, FCA and LSE fees, director fees).
-
Source and negotiate a private target that wishes to obtain a Main Market listing by reverse takeover rather than by IPO.
-
Fund the transaction costs (legal, reporting accountant, sponsor) through convertible debt and warrants until completion.
-
Issue consideration shares to the target's owners on completion, so that existing shell shareholders retain a minority stake in a larger operating company.
The directors explicitly market the company on this basis: in the 28 August 2025 shareholder update they described GCG as among the first companies listed as a clean shell on the Main Market under the revised UK Listing Rules for shell companies, and therefore an attractive partner for companies seeking a Main Market listing via RTO.
Revenue model and mix
| Revenue type | Share of revenue | Comment |
|---|---|---|
| Product | 0% | No products |
| Service | 0% | No services |
| Subscription | 0% | Not applicable |
| Licensing | 0% | Not applicable |
| Other income | Episodic | FY2022 recognised £172,415 of "other income" representing professional fees reimbursable by Bolt Global under the aborted RTO cost-sharing agreement |
| Finance income | Negligible | £720 (FY2025); £1,371 (H1 2026) bank/loan interest |
Value chain position
The company sits in the capital-markets access segment of the corporate finance value chain — a supplier of listing infrastructure to private companies. Its "customers" are, in effect, prospective RTO targets; its "suppliers" are its professional advisers (sponsor, broker, lawyers, auditors, registrar) and its funders (CLN subscribers).
End-markets
Current (shell): UK listed-shell / RTO market; private companies seeking a London listing.
Prospective (post-RTO, if StarEdge completes): datacenter infrastructure — AI-capable server sourcing, sales, leasing and installation; datacenter energy-optimisation hardware/software; quantum-security procurement; quantum chip sales (per the 23 July 2026 Proposed Acquisition Update). The earlier January 2026 description of SSS Matrix additionally referenced applied AI, commodity markets and supply chain management, and blockchain-based digital finance and payments; the July 2026 restructuring narrowed this to datacenter infrastructure.
Strategy
Stated strategy (themes from FY2025 Annual Report and 2026 announcements)
Primary objective: complete the current reverse takeover transaction (StarEdge) during 2026 and create enhanced value for shareholders (Chairman's statement, 13 May 2026).
Pipeline: the Board states it maintains access to a strong pipeline of targets with strong management teams and good growth prospects, should the current transaction fail.
Positioning: market the company as a "clean shell" under the revised UK Listing Rules shell companies regime, offering a faster route to a Main Market listing than an IPO (Shareholder update, 28 August 2025).
Sector focus: originally fintech (2016 IPO); now "financial or other technologies" — in practice broadened to datacenter infrastructure.
Investment process: third-party legal, commercial and financial due diligence, site visits, management meetings and independent valuations where relevant (QCA statement, FY2025).
Strategic initiatives (last 24 months)
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Recapitalisation / refinancing | Apr–Jul 2025 | NE10 Vodka CLN (£300k, later £500k facility; £180k drawn) | Superseded; NE10 refinanced Feb 2026 and repaid Jun 2026 |
| Listing restoration | Aug 2025 | Restored under shell companies category | Achieved 21 Aug 2025; re-suspended Jan 2026 |
| October 2025 CLN programme | Oct 2025 – Jun 2026 | Up to £1.0m, increased to £1.5m; £1.49m raised; 8% coupon; 3p fixed conversion; 1-for-2 warrants at 3p | Fully drawn |
| StarEdge RTO | Jan 2026 – present | Non-binding exclusive heads of terms; share-for-share consideration; target restructured and rebranded July 2026 | In due diligence; sponsor (SPARK) appointed; no SPA signed as at 30 Sep 2026 |
| Simplified prospectus for CLN conversion shares | Announced 23 Jun 2026 | Targeted publication by end-July 2026 | No publication identified in RNS feed through 30 Sep 2026 — appears delayed |
| Cost programme | — | No formal cost programme; costs described as kept to a minimum | — |
| ESG / sustainability commitments | — | — | — |
Medium-term financial targets / guidance
None. The company has issued no financial guidance, no medium-term targets, and no investor day. The only forward-looking commitment is the aspiration to complete the RTO in 2026.
Products & Services
Golden Rock Global plc
The company has no products, brands, platforms or services. Not applicable.
Proposed RTO target — StarEdge Digital Infrastructure Inc. (formerly SSS Matrix Corp.)
| Offering (as described by GCG) | Description | Target customer | Launch / version | Pricing model | Named flagship |
|---|---|---|---|---|---|
| Datacenter hardware & software procurement | Sourcing of hardware/software to improve quantum security, energy usage and computing power | Traditional and new datacenters | — | — | — |
| Server sales, leasing & installation | AI-capable server supply, leasing and installation | Datacenters | — | Sale and lease (terms not disclosed) | — |
| Servicing & maintenance | Maintenance of installed hardware | Datacenters | — | Presumably recurring service contracts — not disclosed | — |
| Quantum chip sales | Sale of quantum chips | — | — | — | — |
| Legacy (pre-restructuring, Jan 2026 description) | Applied AI, commodity trading and supply-chain/logistics management, blockchain-based digital finance and payments, tokenisation contracts | — | Expanded in H2 2025 per GCG | — | — |
The following is drawn solely from the company's 22 January 2026 and 23 July 2026 announcements. No specifications, pricing, launch dates or named flagship products have been publicly disclosed.
Analyst observation. The scope narrowed markedly between January 2026 (a multi-vertical AI/commodities/blockchain group) and July 2026 (a datacenter infrastructure business). Whether legacy commodity-trading, logistics and tokenisation activities were divested, retained outside the perimeter, or reclassified is not disclosed. Investors should require the prospectus to reconcile the two descriptions.
Historical (aborted) targets — for context
| Target | Period | Offering |
|---|---|---|
| Bolt Global Limited | Nov 2021 – Apr 2023 | Blockchain-based media and decentralised finance ecosystem |
| 2Mee Limited | Aug 2023 – Aug 2024 | Patented omnichannel communication platform delivering influencers as on-screen web and app messages; product lines HoloAd® and HoloMessage® |
Financial Narrative
Sources: FY2021 and FY2022 — FY2022 Annual Report (RNS 28 April 2023); FY2024 and FY2025 — FY2025 Annual Results (RNS 14 May 2026); FY2023 — derived from opening balances in the FY2025 Annual Report statement of changes in equity and cash flow statement (the FY2023 accounts themselves, published 22 July 2025, were not available in full in the sources reviewed). H1 figures from interim statements. Blank cells = not obtained / not publicly disclosed in sources reviewed.
Income statement
Notes: (a) FY2021 directorship fees are a net credit of £80,958 because three directors waived accumulated accrued remuneration of £127,500 (FY2022 Annual Report, note 7). (b) EBITDA equals operating loss — the company has no depreciation or amortisation. (c) FY2025 directorship fees of £97,378 include a £51,128 share-based charge for director warrants; cash fees were £46,250 (£17,500 Paul Carroll; £28,750 John Croft). (d) The FY2025 income statement prints the net loss as £865,397 in one line and £865,367 elsewhere; £865,367 is used here. (e) Loss per share figures are reported as negative values (losses); shown here as positive magnitudes.
Half-year comparison
Source: H1 2026 Interim Statements (RNS 30 Sep 2026). Note the H1 2026 chairman's statement describes the H1 2026 figure of £656,355 as the "operating loss"; the income statement shows operating loss of £629,037 and loss before tax of £656,355.
Margins and growth
All margin metrics are not meaningful (zero revenue). Revenue CAGR FY2021–FY2025: not meaningful (zero base and zero end).
Balance sheet
Notes: (a) Working capital equals total equity because all assets and liabilities are current. (b) CLN principal largely sits within equity (as "prepaid equity" and "equity options") under management's IAS 32 classification, which the auditor disputes (see 6.8). On the auditor's view, the £585,000 of CLNs outstanding at 31 Dec 2025 would be classified as financial liabilities, which would make FY2025 equity substantially negative and net debt positive. (c) FY2023 equity: the statement of changes in equity shows −£70,162, while the components sum to approximately −£69,442 — a minor internal inconsistency in the company's figures.
30 June 2026 balance sheet (H1 2026 Interims): cash £728,659; loan receivable (to chairman) £80,587; other receivables £11,116; total assets £820,362; trade creditors £164,291; accruals £32,685; financial liability nil; total liabilities £196,976; equity £623,386 (including prepaid equity £1,163,957 and equity options £471,023); accumulated losses £3,742,339.
Cash flow
FY2023 CLN figure reflects the £100,000 Wei Chen CLN drawn 10 January 2023 (FY2022 Annual Report, note 17); FY2023 net change in cash derived from closing cash £34,335 (FY2022) to £9,797 (FY2023). The July 2023 placing of 3,800,000 shares at 2.5p (gross £95,000) also fell in FY2023; operating cash flow for FY2023 was not obtained.
H1 2026 cash flow (Interims): operating cash outflow £369,892; loan advance to director £80,000; repayment to NE10 £130,000 (per cash flow; the related-party note separately records a £145,000 payment on 30 June 2026 creating a £4,606 overpayment receivable); CLN prepayments received £1,035,000; share issue £659; net cash increase £455,767.
Ratios
ROE, ROIC, debt/equity, net debt/EBITDA, interest coverage and cash conversion cycle are not meaningful (negative or near-zero equity in several years, negative EBITDA, no revenue, no inventory or receivables cycle). ROA computed on average total assets: FY2022 £165,906 / £164,865; FY2025 £865,367 / £144,196.
Commentary on trends, inflections and drivers
Cost base. In "dormant" years the shell's cash running cost is modest — roughly £100,000–£150,000 per year (FY2021 underlying, FY2024). Costs spike whenever a transaction is live: FY2022 professional fees of £257,892 reflected the Bolt RTO (partly offset by £172,415 reimbursable by Bolt), and H1 2026 professional fees of £316,449 reflect StarEdge transaction work. The FY2025 headline loss of £865,367 is inflated by £529,322 of non-cash warrant charges; the cash-adjusted loss was £315,816.
Inflection in 2025. FY2024 was the trough: cash of just £1,867 against £217,857 of liabilities, negative equity of £209,574, and a suspension caused by the inability to pay for an audit. The 2025 recapitalisation (NE10 CLN, October CLN, broker warrant exercise) lifted cash to £272,892 by year-end and to £728,659 by 30 June 2026, while creditor settlements at a discount reduced trade creditors from £87,277 to £13,105.
Cost of the recapitalisation. The recovery was purchased with heavy dilution instruments: 22,750,000 warrants struck at £0.00021978 (essentially nil-cost), 3,340,000 director warrants at 0.3p, CLN-linked warrants at 3p, and £1.49m of CLNs convertible at 3p. Accumulated losses rose from £2.22m to £3.74m in eighteen months.
Cash runway. H1 2026 operating cash burn of £369,892 implies roughly £60,000–£65,000 per month while the RTO is live. Against £728,659 of cash at 30 June 2026 (plus the £80,587 director loan due back 18 October 2026), the runway on that run-rate is about 11–13 months from 30 June 2026 — but RTO completion costs (sponsor, reporting accountant, prospectus) and abort costs could compress this materially. The CLN facility is fully drawn.
Audit quality flags
FY2025 — qualified opinion: (PKF Littlejohn, 13 May 2026): the auditor disagreed with management's IAS 32 classification of the June and October 2025 CLNs (total £585,000 due at year-end, of which £122,452 was allocated to equity as an embedded derivative), stating the derivative and host contract should be financial liabilities.
- FY2025 — material uncertainty on going concern, with the forecast materially reliant on the £1m Shin Nieh Group CLN subscription executed 24 April 2026.
FY2022 — material uncertainty on going concern: (unmodified opinion).
Late filings: FY2023 audit could not be completed on time (suspension August 2024); FY2023 and FY2024 accounts were only published on 22 July 2025; FY2025 accounts missed the 30 April 2026 deadline and were published 14 May 2026.
Internal controls: the FY2025 report states the Board considers internal controls "no more than adequate" and that a more comprehensive system needs implementing immediately.
Interim document errors: the H1 2026 chairman's statement gives the 30 June 2025 cash comparative as £272,892 (which is actually the 31 December 2025 figure; the H1 2025 figure was £85,500).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Jurisdiction | Ownership | Function | Status |
|---|---|---|---|---|
Golden Rock Global plc | Jersey (no. 121560) | Listed parent | Listed cash shell | Active; shares suspended |
Golden Rock Services Limited | England & Wales (no. 13036001) | 100% | Held cash and operated UK banking until 31 March 2025 | Dormant since 31 March 2025 |
Revenue by Segment (GBP)
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Cash shell (single segment) revenue (GBP) | 0 | 0 | 0 |
Cash shell operating loss (GBP) | — | 127,919 | 845,858 |
Cash shell loss before tax (GBP) | 287,334 | 131,816 | 865,367 |
Income Statement (GBP) and Share Count (millions)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (GBP) | 0 | 0 | 0 | 0 | 0 |
Gross profit (GBP) | 0 | 0 | 0 | 0 | 0 |
Professional fees (GBP) | 149,304 | 257,892 | — | 97,902 | 202,883 |
Directorship fees net (GBP) | -80,958 | 55,000 | — | 26,900 | 97,378 |
Other expenses (GBP) | 24,910 | 25,429 | — | 3,117 | 67,403 |
Share-based payments (GBP) | 0 | 0 | — | 0 | 478,194 |
Total operating costs (GBP) | 93,256 | 338,321 | — | 127,919 | 845,858 |
Other income (GBP) | 0 | 172,415 | — | 0 | 0 |
Operating loss (GBP) | 93,256 | 165,906 | — | 127,919 | 845,858 |
EBITDA loss (GBP) | 93,256 | 165,906 | — | 127,919 | 845,858 |
Finance income (GBP) | 0 | 0 | — | 0 | 720 |
Finance costs (GBP) | 0 | 0 | — | 3,897 | 20,229 |
Loss before tax (GBP) | 93,256 | 165,906 | 287,334 | 131,816 | 865,367 |
Tax (GBP) | 0 | 0 | 0 | 0 | 0 |
Net loss (GBP) | 93,256 | 165,906 | 287,334 | 131,816 | 865,367 |
Basic & diluted loss per share (pence) | 0.49 | 0.87 | — | 0.57 | 3.34 |
Weighted average shares (millions) | 19.175 | 19.175 | — | 22.975 | 25.884 |
Dividends per share (pence) | 0 | 0 | 0 | 0 | 0 |
Key Financials (GBP)
| Metric | H1 2025 | H1 2026 |
|---|---|---|
Professional fees (GBP) | 95,708 | 316,449 |
Directorship fees (GBP) | 16,250 | 40,000 |
Other expenses (GBP) | 108 | 100,687 |
Share-based payments (GBP) | 0 | 171,901 |
Operating loss (GBP) | 112,066 | 629,037 |
Fair value loss through P&L (GBP) | 174,935 | 6,471 |
Finance costs (GBP) | 1,712 | 22,218 |
Loss before tax (GBP) | 288,713 | 656,355 |
Loss per share (pence) | 1.26 | 2.54 |
Cash-adjusted loss (GBP) | 112,066 | 466,160 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Net loss YoY change (%) | 78 | 73 | -54 | 556 |
Balance Sheet (GBP) and Share Count (millions)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash and equivalents (GBP) | 182,974 | 34,335 | 9,797 | 1,867 | 272,892 |
Other receivables (GBP) | 5,336 | 107,085 | — | 6,416 | 7,217 |
Total assets (GBP) | 188,310 | 141,420 | — | 8,283 | 280,109 |
Trade creditors (GBP) | 2,613 | 101,102 | — | 87,277 | 13,105 |
Accruals (GBP) | 23,000 | 43,527 | — | 126,003 | 83,117 |
Financial liability – CLN (GBP) | 0 | 0 | — | 4,577 | 111,706 |
Total liabilities (GBP) | 25,613 | 144,629 | — | 217,857 | 207,928 |
Short-term debt (GBP) | 0 | 0 | — | 4,577 | 111,706 |
Long-term debt (GBP) | 0 | 0 | 0 | 0 | 0 |
Net debt (cash) (GBP) | -182,974 | -34,335 | — | 2,710 | -161,186 |
Total equity (GBP) | 162,697 | -3,209 | -70,162 | -209,574 | 72,181 |
Accumulated losses (GBP) | 1,634,841 | 1,800,747 | 2,088,081 | 2,220,617 | 3,085,984 |
Goodwill & intangibles (GBP) | 0 | 0 | 0 | 0 | 0 |
Working capital (GBP) | 162,697 | -3,209 | — | -209,574 | 72,181 |
Shares in issue (millions) | 19.175 | 19.175 | 22.975 | 22.975 | 31.325 |
Cash Flow (GBP)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (GBP) | -43,929 | -148,639 | — | -7,930 | -409,975 |
Capex (GBP) | 0 | 0 | 0 | 0 | 0 |
Free cash flow (GBP) | -43,929 | -148,639 | — | -7,930 | -409,975 |
Equity issued (GBP) | 198,438 | 0 | — | 0 | 96,000 |
CLN / prepaid equity raised net (GBP) | 0 | 0 | 100,000 | 0 | 585,000 |
Dividends paid (GBP) | 0 | 0 | 0 | 0 | 0 |
Buybacks (GBP) | 0 | 0 | 0 | 0 | 0 |
Net change in cash (GBP) | 154,509 | -148,639 | -24,538 | -7,930 | 271,025 |
Financial Ratios (x) and Returns & Leverage Ratios (%)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Current ratio (x) | 7.35 | 0.98 | — | 0.04 | 1.35 |
Cash / current liabilities (x) | 7.14 | 0.24 | — | 0.01 | 1.31 |
ROA (%) | — | -101 | — | — | -600 |
Asset turnover (x) | 0 | 0 | 0 | 0 | 0 |
Geographic Revenue
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
United Kingdom revenue (GBP) | 0 | 0 | 0 |
Jersey revenue (GBP) | 0 | 0 | 0 |
Rest of world revenue (GBP) | 0 | 0 | 0 |
Total revenue (GBP) | 0 | 0 | 0 |
Data Point Details
| Data point | Value | Source / date |
|---|---|---|
Implied IPO price | Approximately 10p (derived: share capital £160,000 + share premium £1,439,100 for 16,000,000 shares at 1 Jan 2021) | FY2022 AR statement of changes in equity |
June 2023 price | 3.23p (up 13% on the day; traded as high as 4.00p that month) | Alliance News, 28 Jun 2023 |
July 2023 placing price | 2.5p | FY2025 AR note 15 |
April 2025 market cap | £700.7k (implies ~3.05p on 22.975m shares) | TipRanks, Apr 2025 |
September 2025 market cap | £605.6k | TipRanks, Sep 2025 |
Share price used in Oct 2025 CLN warrant valuation | 3.30p | FY2025 AR note 17 |
Last traded price (pre-suspension) | 3.45p | Morningstar UK, May 2026; H1 2026 note 10 valuation input |
Current market cap (stale) | ~£1.18m (3.45p × 34.25m) | Calculated |
Operating Metrics (millions)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Shares in issue year-end (millions) | 19.175 | 19.175 | 22.975 | 22.975 | 31.325 |
Warrants outstanding year-end (millions) | 4.055 | 4.055 | 5.4 | 5.4 | 35.273 |
Dividends per share (pence) | 0 | 0 | 0 | 0 | 0 |
Components
| Component | Shares (m) | Basis |
|---|---|---|
Ordinary shares in issue | 34.25 | H1 2026 note 8 |
Warrants outstanding | 49.52 | H1 2026 note 10 |
CLN principal conversion at 3p | 49.67 | £1,490,000 ÷ £0.03 |
CLN accrued interest conversion (8% p.a., to maturity) | Up to ~11.9 | Analyst estimate: 3 years × 8% × £1.49m ÷ £0.03; coupon converts at maturity |
Indicative fully diluted total | ~145 | Before RTO consideration shares and any RTO fundraising |
Valuation Multiples
| Multiple | GCG | Comment |
|---|---|---|
P/E | n/m | Loss-making |
EV/EBITDA | n/m | Negative EBITDA |
EV/Sales | n/m | Zero revenue |
P/B | ~1.9x | £1.18m market cap ÷ £623,386 book equity (30 Jun 2026); equity includes CLN-related reserves disputed by auditor |
Market cap / cash | ~1.6x | £1.18m ÷ £0.73m cash; implies ~£0.45m premium for the listing and option on RTO |
Analyst Conclusions
Management guidance
No financial guidance. Management's stated aim is to complete the StarEdge RTO in 2026 (FY2025 Chairman's statement); the H1 2026 statement (29 Sep 2026) acknowledges unexpected delays due to StarEdge's reorganisation and promises further updates in due course.
Consensus growth expectations
None — no analyst coverage.
Bull case
-
Transaction is funded and staffed. Unlike 2024, the company has cash (£728,659 at 30 June 2026), a fully subscribed CLN programme (£1.49m) and an appointed sponsor (SPARK), removing the funding failure mode that killed the 2Mee deal.
-
Thematic tailwind. StarEdge targets AI-datacenter server supply, energy optimisation and quantum security — areas of strong investor interest that could support the required contemporaneous fundraising.
-
Low entry valuation for the option. At ~£1.2m market cap (~1.6x cash), shell holders hold a cheap option on an RTO that, if StarEdge has genuine revenue, could re-rate the enlarged entity well above the shell value.
Bear case
-
Track record. Two prior RTOs collapsed (2023, 2024) after prolonged suspensions; the current deal is still non-binding nine months after announcement and the target has already restructured.
-
Dilution and capital structure. ~145m fully diluted shares pre-RTO (vs 34m in issue), including 22.75m warrants issued at ~0.02p, mean existing holders' economic interest is thin; a Rule 9 whitewash implies vendors will take control.
-
Governance and reporting quality. Qualified FY2025 audit, repeated late filings, internal inconsistencies across documents (share count, cash comparative, net loss), and an undisclosed related-party loan to the chairman undermine confidence in the information that will underpin the prospectus.
Catalysts and monitorables (next 12 months)
| Catalyst | Expected timing | Why it matters |
|---|---|---|
| Repayment of £80k loan to chairman | Due 18 October 2026 | Test of governance; non-repayment would be a red flag |
| Signing of definitive SPA with StarEdge | Not guided | Converts non-binding HoT into binding deal; triggers UKLR 13.4.22R disclosure |
| Publication of simplified prospectus for CLN conversion shares | Was targeted end-July 2026 | Overdue; signals FCA engagement |
| Disclosure of StarEdge audited financials | With prospectus | First view of target revenue, profitability, jurisdiction, ownership |
| Identity of Shin Nieh Group and any links to StarEdge | Prospectus / RNS | Concert-party and Rule 9 implications |
| RTO fundraising size and price | At readmission | Determines final dilution and enlarged-group valuation |
| Rule 9 waiver vote | General meeting pre-completion | Independent shareholder approval |
| Cash burn vs £0.73m (June 2026) | Ongoing | Risk of further CLN/warrant issuance if delays persist |
| FY2026 audit opinion | By 30 April 2027 | Whether qualification on CLN classification recurs |
| Lapse/restoration of suspension | Event-driven | If StarEdge fails, company must apply for restoration |
Concluding analyst verdict
Golden Rock Global plc is not an operating company and cannot be valued on any conventional metric: it has generated no revenue in ten years of listed existence, has no employees, and its only assets are roughly £0.8m of current assets and a Main Market shell listing.
The 2025–2026 recapitalisation was genuinely consequential. It rescued a shell that, at end-2024, had under £2,000 of cash and could not afford its own audit, and it has funded a credible advisory team for the current transaction. That is the principal difference between this attempt and the failed 2Mee deal. However, the price of that rescue has been a capital structure in which existing ordinary shares represent only about a quarter of the pre-RTO fully diluted count, with a large tranche of warrants exercisable at effectively nil cost. Any RTO will also hand control to the vendors.
Governance is the dominant concern. A qualified audit, three late annual reports in three years, internally inconsistent figures, and an undisclosed material loan to the chairman — himself a director of a former lender — fall well short of the standard investors should expect from the vehicle through which a new business will be presented to the market. The shift in the target's described business between January and July 2026 heightens the need for rigorous prospectus disclosure.
Verdict: highly speculative. The near-term decision points are repayment of the chairman's loan (due 18 October 2026), signature of a binding SPA, and the first disclosure of StarEdge's audited financials. Absent those, the probability-weighted value of the shell should be anchored to its net cash, discounted for ongoing burn and abort costs.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Appointed | Tenure | Background (per company disclosures) |
|---|---|---|---|---|
Paul Carroll | Non-Executive Chairman | 30 May / 4 Jun 2025 (both dates appear in FY2025 report) | ~1.3 years | Entrepreneur and C-suite executive; founded and developed businesses in manufacturing, technology and digital sectors in the UK, USA and Canada; specialises in sustainable business modelling, growth capital financing and M&A; director of NE10 Vodka Ltd |
John Croft | Independent Non-Executive Director (company contact) | 2016 | ~10 years | Board director focused on governance; served on boards and committees of international companies in financial services, resources and TMT, including LSE-listed companies based in Malaysia, Hong Kong, China and Australia; based in Dubai; principal of Croft International Partners (per email domain) |
Directors' Remuneration
| Director | Cash fees FY2025 (GBP) | Share-based FY2025 (GBP) | Total FY2025 (GBP) | Total FY2024 (GBP) |
|---|---|---|---|---|
Paul Carroll | 17,500 | 25,564 | 43,064 | 0 |
John Croft | 28,750 | 25,564 | 54,314 | 25,000 |
Ross Andrews | 0 | 0 | 0 | 1,900 |
Wei Chen | 0 | 0 | 0 | 0 |
Total | 46,250 | 51,128 | 97,378 | 26,900 |
Directors' Shareholdings
| Director | Ordinary shares | % | Warrants |
|---|---|---|---|
Paul Carroll | 0 | 0 | 1,670,000 |
John Croft | 0 | 0 | 2,070,000 (400,000 at 2.5p expiring 20 Jul 2026, plus 1,670,000 at 0.3p) |
Ross Andrews (resigned) | 0 | 0 | 400,000 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Apr 2025 | Ross Andrews resigns as Chairman | Followed collapse of 2Mee deal and FY2023 audit funding crisis |
3 Apr 2025 | Paul Carroll announced to join board | Linked to NE10 Vodka refinancing |
30 May 2025 | Wei Chen (founder, executive director) resigns | Coincides with capital reorganisation; Chen family no longer among disclosed substantial holders by Jan 2026 |
May/Jun 2025 | Paul Carroll appointed; becomes Chairman | — |
Major Shareholders
| Holder | Shares | % |
|---|---|---|
Leon Hogan | 5,400,000 | 15.72 |
GBS Banking Group | 4,480,000 | 13.04 |
Green Coast Capital LLC | 4,390,000 | 12.78 |
James Brearley & Sons | 3,800,000 | 11.06 |
John Nemanic | 3,680,000 | 10.71 |
Tiger Trout Capital LLC | 3,675,000 | 10.70 |
Disclosed total | 25,425,000 | 74.01 |
Competitive Landscape
Key Competitors
| Competitor category | Description | Relative positioning vs GCG |
|---|---|---|
Other LSE Main Market shell companies (Equity Shares – Shell Companies category) | Listed cash shells pursuing RTOs | GCG claims "first mover" status under the revised regime; however, its ten-year record of two failed RTOs and repeated suspensions is a reputational weakness |
AIM-quoted cash shells / investing companies | Shells on AIM, subject to AIM rules on time limits for completing acquisitions | AIM shells face nominated adviser oversight and time-bound deployment; Main Market listing may appeal to targets wanting higher-profile status |
Aquis Stock Exchange (AQSE) shells | Lower-cost growth market shells | Cheaper, less prestigious; competes for smaller targets |
Direct IPO on LSE Main Market / AIM | Traditional IPO with bookbuild | Provides cleaner capital structure; RTO via GCG offers speed but carries GCG's dilution overhang |
US SPACs / de-SPAC transactions | Larger US blank-cheque vehicles with trust cash | Far greater cash in trust; GCG has no trust account |
Overseas exchanges (e.g., Nasdaq, NYSE American, HKEX GEM, ASX) | Alternative listing venues | Relevant to a StarEdge-type target with international operations |
Competitors by Segment
| Segment | Named competitors | Comment |
|---|---|---|
AI-capable servers (sales/leasing/installation) | Super Micro Computer, Dell Technologies, Hewlett Packard Enterprise, Lenovo | Global OEMs with direct supply relationships to GPU vendors; a small reseller/lessor competes on sourcing access, financing and service |
Datacenter power and energy optimisation | Schneider Electric, Vertiv, Eaton | Dominant in power, cooling and energy management |
Quantum security / post-quantum cryptography | IBM, PQShield | Large-vendor and specialist PQC providers |
Quantum hardware / chips | IBM Quantum, IonQ, Quantinuum, Rigetti Computing | Capital-intensive; StarEdge's role (manufacturer vs reseller) is not disclosed |
Datacenter maintenance / services | OEM service arms; independent third-party maintenance providers | Fragmented |
Peer Comparison FY2025
| Company | FY2025 revenue | R&D intensity |
|---|---|---|
Golden Rock Global plc | £0 | 0% |
Super Micro Computer | Approx. | — |
Dell Technologies | Approx. | — |
Vertiv | Approx. | — |
Recent Developments
No contract wins, product launches, layoffs or litigation (the company has no operations).



